Phenylalanine Hydroxylase
Phenylalanine Hydroxylase - Related Videos
01:27
Cofactors and Coenzymes
0 Views •
2019
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds. Cofactors are present in ~30% of mature proteins. They are frequently incorporated into an enzyme as it is folded and are involved in the enzyme’s catalytic activity. Magnesium is an...
01:49
Conserved Binding Sites
0 Views •
2020
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function. Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
03:14
Immunohistochemistry for Identifying the Locus Coeruleus Region in Mouse Brain Sections
0 Views •
2025
This protocol outlines the use of immunohistochemistry to identify locus coeruleus regions in mouse brain sections. By targeting dopamine β-hydroxylase with green fluorophore-labeled antibodies, norepinephrine-producing neurons are visualized as green fluorescence under a microscope.
02:42
Immunohistochemistry of Mouse Brain Tissue Sections for Targeting Dopamine Neurons
0 Views •
2025
Source: Kummari, E., et. al., Laser Capture Microdissection - A Demonstration of the Isolation of Individual Dopamine Neurons and the Entire Ventral Tegmental Area., J. Vis. Exp. (2015)In this video, we demonstrate the immunohistochemistry protocol for dopamine neurons in brain tissue sections for subsequent laser capture microdissection.
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
0 Views •
Cited by 44 •
2012
Dopamine is distinctly regulated in the midbrain nuclei, which contain the cell bodies and dendrites of the dopamine neurons. Here we describe a dissection and sample-handling approach to maximize results, and thus conclusions and insights, on dopamine regulation in the midbrain nuclei of the substantia nigra (SN) and ventral tegmental area (VTA) in rodents.
FAQs
Phenylalanine hydroxylase depends on three distinct chemical components during hydroxylation: molecular oxygen, iron located at the enzyme’s active site, and tetrahydrobiopterin as a cofactor. Their coordinated involvement enables phenylalanine to be converted into tyrosine. This illustrates how enzyme activity relies not only on the protein itself but also on required molecular partners and reaction conditions.
Tetrahydrobiopterin is not simply used once and discarded. After participating in phenylalanine hydroxylation, it is regenerated through additional enzymatic reactions. This regeneration supports continued cofactor availability and therefore ongoing conversion of phenylalanine to tyrosine. The cycle provides an important example of how linked enzymatic reactions sustain a metabolic pathway.
When phenylalanine hydroxylase activity is reduced or absent, phenylalanine is not efficiently converted into tyrosine and begins to accumulate. This abnormal buildup is associated with phenylketonuria, or PKU. The relationship connects a change in enzyme function with a measurable metabolic consequence and explains why inherited enzyme deficiencies can produce clinically important disorders.
The reaction has significance because tyrosine is linked to the production of several biologically important molecules. Consequently, phenylalanine hydroxylase participates in more than the removal or processing of one amino acid. Studying this step helps biology researchers connect amino acid metabolism with broader biochemical processes that depend on tyrosine availability.
The liver is identified as the site where phenylalanine hydroxylation occurs, making it central to understanding the enzyme’s physiological role. Focusing on this organ places the reaction within amino acid metabolism rather than treating it as an isolated laboratory event. It also provides relevant context for investigating how impaired activity contributes to PKU.
Phenylalanine hydroxylase research provides the biochemical context for newborn screening because reduced or absent enzyme activity produces phenylalanine accumulation and PKU. Understanding this enzyme helps connect an inherited metabolic abnormality with the need to identify the disorder early. Screening therefore represents an important application of knowledge about enzyme function and its metabolic consequences.
Dietary management is relevant when phenylalanine hydroxylase activity is insufficient because the enzyme normally processes phenylalanine into tyrosine. Reduced conversion leads to phenylalanine accumulation, creating a metabolic problem that can be addressed through management strategies. Studying the enzyme therefore supports both understanding of PKU and development of approaches for controlling its biochemical consequences.
Because impaired phenylalanine hydroxylase activity is associated with PKU, the enzyme provides a target for emerging enzyme-targeted therapies. Research in this area builds on the pathway’s specific biochemical defect rather than addressing amino acid metabolism generally. Such work complements newborn screening and dietary management by investigating ways to respond more directly to the underlying enzyme-related problem.